{
  "paper_metadata": {
    "pmid": "38549855",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val142Ile, including penetrance data and individual patient details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 4,
        "demographics": "African American, ages 18 to 65",
        "phenotype": "hypertrophic cardiomyopathy (HCM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 4,
        "affected_count": 4,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 34,
          "age_at_onset": 16,
          "age_at_diagnosis": 16,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "mid-ventricular phenotypic HCM",
          "evidence_sentence": "Patient 1 is a 34-year-old African American man with a history of mid-ventricular phenotypic HCM and found to have a Val142Ile variant."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "basal septal phenotypic HCM",
          "evidence_sentence": "Patient 2 is a 65-year-old African American woman with newly diagnosed basal septal phenotypic HCM discovered after episodes of NSVT for which an ICD was placed."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 57,
          "age_at_onset": 21,
          "age_at_diagnosis": 21,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "basal septal phenotype HCM",
          "evidence_sentence": "Patient 3 is a 57-year-old African-American woman with a history of basal septal phenotype HCM diagnosed at age 21 years due to the detection of a heart murmur."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 18,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "apical phenotype HCM",
          "evidence_sentence": "Patient 4 is an 18-year-old African American man with a new diagnosis of apical phenotype HCM that was discovered after a presyncopal episode while playing basketball."
        }
      ],
      "functional_data": {
        "summary": "The TTR Val142Ile variant is associated with hypertrophic cardiomyopathy but does not show evidence of amyloidosis in the studied patients.",
        "assays": []
      },
      "segregation_data": "Not explicitly mentioned in the paper.",
      "population_frequency": "4.7% prevalence in cohort of patients with phenotypic HCM.",
      "evidence_level": "Strong evidence based on clinical presentation and genetic testing.",
      "source_location": "Discussion, paragraph 1",
      "additional_notes": "All patients with the TTR Val142Ile variant were Black, indicating a potential population-specific prevalence.",
      "key_quotes": [
        "The presence of pathogenic TTR gene variants in patients with phenotypic HCM is an underrecognized and clinically important entity.",
        "In our cohort of patients with phenotypic HCM undergoing genetic testing, the overall prevalence of concomitant TTR Val142Ile variant was 4.7%."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR variant Val142Ile was extracted successfully."
  }
}